Hip News

Corin has received FDA 510(k) clearance of its Icona femoral stem for direct anterior total hip arthroplasty with design considerations for use in the ASC setting, according to a press release.

DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed 14 days may be the optimal cutoff time for glucagon-like peptide-1 receptor agonists prior to primary hip or knee arthroplasty.

The American Joint Replacement Registry released its 2024 report on trends in arthroplasty, according to a presenter at the American Association of Hip and Knee Surgeons Annual Meeting.

DALLAS — In this video, Joshua C. Rozell, MD, discussed outcomes of an 11-year retrospective analysis that showed several factors may increase the risk of wound complications after direct anterior total hip arthroplasty.

DALLAS — In this video, Sumon Nandi, MD, MBA, discussed results of a novel total joint arthroplasty discharge protocol that does not require formal physical therapy clearance for same-day discharge.

According to published results, glucagon-like peptide-1 agonists may not be associated with increased complications for patients with diabetes who undergo total hip arthroplasty.

Allopathic vs. osteopathic medical education does not impact a surgeon’s clinical outcomes, according to data published in JAMA Surgery.

PHILADELPHIA — Outcomes from a total joint replacement enhanced recovery after surgery program indicated that a novel data mart dashboard may improve outcomes for an institution and its ability to provide feedback to stakeholders.

According to published results, patients who traveled 40 miles or more to undergo total hip arthroplasty had similar 90-day outcomes and complication rates compared with patients who traveled fewer than 40 miles for surgery.

OrthAlign Inc. announced it received FDA 510(k) clearance for its Lantern hip handheld technology for use in total hip arthroplasty procedures, according to a company press release.